BSE filing, NSE: AKUMS. Summary written from the filing by ALFA Finder's alert engine.
Akums Drugs & Pharmaceuticals Ltd: key numbers
- Share price
- ₹717.95
- Market cap
- ₹11,300 Cr
- Revenue (annual)
- ₹4,359 Cr
- Net profit (annual)
- ₹255.2 Cr
- P/E (TTM)
- 38.7×Sector 46.5×
- Promoter holding
- 75.26%+0.00% QoQ
- FII holding
- 4.50%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Akums Drugs & Pharmaceuticals Ltd
All →Akums Drugs & Pharmaceuticals Legal & Regulatory
Akums Drugs and Pharmaceuticals received a ₹52.75 Crore NPPA demand notice. The company claims no liability, citing an indemnity agreement with its marketer.
- Value
- ₹52.75 Cr
Akums Drugs & Pharmaceuticals Other Announcement
Akums Drugs and Pharmaceuticals Ltd submitted its quarterly shareholding pattern for the period ended September 30, 2026. The filing notes the removal of two entities from the promoter group.
Akums Drugs & Pharmaceuticals Other Announcement
Akums Drugs and Pharmaceuticals received an ESG rating of 65 for FY2025-26 from NSE Sustainability Ratings & Analytics Limited. The rating was assigned voluntarily based on publicly available information.
Akums Drugs & Pharmaceuticals Other Announcement
Akums Drugs and Pharmaceuticals Limited has cancelled its participation in the Antique Healthcare Investor Conference scheduled for August 25, 2026, due to unavoidable medical reasons.
Akums Drugs & Pharmaceuticals Earnings Call Transcript: Key Takeaways
Akums reported strong Q1FY27 performance with 13.9% revenue growth and 56.1% PAT increase. Results were driven by a robust 18.6% growth in the CDMO segment and improved API pricing.
Akums Drugs & Pharmaceuticals Other Announcement
The company filed its quarterly shareholding pattern for the period ended September 30, 2025, in compliance with SEBI LODR regulations.
Other board meeting date announcements
All →ESDS Software Solution Board Meeting Date
ESDS Software Solution will hold a board meeting on 2 November 2026 to consider unaudited standalone and consolidated results for Q2 and half-year. This is a prior intimation of a future meeting with no decision yet taken.
Mrugesh Trading Board Meeting Date
Mrugesh Trading will hold a board meeting on 31 October 2026 to consider unaudited Q2 and half-year results. This is a prior intimation of a future meeting, with no decision yet taken.
Add-Shop E-Retail Board Meeting Date
Add-Shop E-Retail will hold a board meeting on 2 November 2026 to consider unaudited quarterly and half-year results. Video conferencing is the mode.
Polymechplast Machines Board Meeting Date
Polymechplast Machines will hold a board meeting on November 4, 2026 to consider unaudited half-year results. Trading window stays closed until 48 hours after the results.
Scarnose International Board Meeting Date
Scarnose International will hold a board meeting on 2 November 2026 to consider unaudited half-year results. The agenda remains proposed until the meeting occurs.
Nitin Castings Board Meeting Date
Nitin Castings will hold a board meeting on 2 November 2026 to consider September 2026 half-year unaudited results. Trading window stays closed until results are declared.